Abstract: A structured document search system comprises an index storage unit and a search unit. The index storage unit stores indexes caused to correspond to the nodes included in the structured documents stored in a database. The indexes include node information items about the nodes to which the indexes are caused to correspond and position information items about related nodes. The node information items include position information items about the nodes to which the indexes are caused to correspond. The search unit, when the search condition specified in the search request made by the client includes value search conditions covering the values of nodes and is a specific search condition specifying a search of a related node common to the nodes, searches the index storage unit for indexes complying with the value search conditions and acquires a position information item about a related node common to the indexes searched for.

Abstract: A definition data storage unit stores definition data defining a rule for transforming tabular form data into a structured document. The definition data includes a conditional repeat specifying description specifying grouping of part of tabular form data rows which corresponds to a common item having a single value. The conditional repeat specifying description includes the common item as an attribute value for a condition for repetition. The definition data further includes a portion into which the tabular form data is inserted as content of an element. The portion includes a value insertion specifying description made to correspond to an item name of an item included in the tabular form data. A transformation unit transforms tabular form data based on the definition data, with the part of the rows grouped as one group, and embeds the value of the item name in a portion specified by the value insertion specifying description.

Abstract: The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical: wherein R1 and R2 are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R3 represents a hydrogen atom or the like; and R6 represents a hydrogen atom or the like. This compound has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor, and is useful as an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage.

Abstract: A structured document search system comprises an index storage unit and a search unit. The index storage unit stores indexes caused to correspond to the nodes included in the structured documents stored in a database. The indexes include node information items about the nodes to which the indexes are caused to correspond and position information items about related nodes. The node information items include position information items about the nodes to which the indexes are caused to correspond. The search unit, when the search condition specified in the search request made by the client includes value search conditions covering the values of nodes and is a specific search condition specifying a search of a related node common to the nodes, searches the index storage unit for indexes complying with the value search conditions and acquires a position information item about a related node common to the indexes searched for.

Abstract: The present invention provides a compound represented by the formula (1) or a pharmacologically acceptable salt thereof, or a hydrate thereof (provided that a compound in which all of R4a, R4b, and R4c are hydrogen atoms is excluded.): [wherein R1 represents a hydrogen atom, R2 represents a hydrogen atom, R3 represents the formula: wherein R4a, R4b, and R4c are the same as or different from each other and each represents a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, etc.

Abstract: A definition data storage unit stores definition data defining a rule for transforming tabular form data into a structured document. The definition data includes a conditional repeat specifying description specifying grouping of part of tabular form data rows which corresponds to a common item having a single value. The conditional repeat specifying description includes the common item as an attribute value for a condition for repetition. The definition data further includes a portion into which the tabular form data is inserted as content of an element. The portion includes a value insertion specifying description made to correspond to an item name of an item included in the tabular form data. A transformation unit transforms tabular form data based on the definition data, with the part of the rows grouped as one group, and embeds the value of the item name in a portion specified by the value insertion specifying description.

Abstract: The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical: wherein R1 and R2 are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R3 represents a hydrogen atom or the like; and R6 represents a hydrogen atom or the like. This compound has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor, and is useful as an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage.

Abstract: A structured document retrieval system includes a structured document database which manages a structured document by a tree structure including a plurality of hierarchical nodes, a unit which receives a traverse request from a client, the traverse request including base point node designation information to designate one of nodes in the structured document database as a base point node corresponding to a base point for retrieval and relative location information to designate a location of a traverse destination node relative to the base point node, and a traverse processing unit which performs a traverse process to move from the one of nodes designated by the base point node designation information to another one of the nodes in accordance with the relative location information, and acquires data corresponding to the traverse destination node from the structured document database.

Abstract: The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical: wherein R1 and R2 are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R3 represents a hydrogen atom or the like; and R6 represents a hydrogen atom or the like. It is an object of the present invention to discover an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage, which has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor.

Abstract: It is intended to provide an animal model of urinary dysfunction induced by damage in brain nerve tissue in a small animal conveniently and at a high reproducibility. A rat in which the central urinary function alone is specifically damaged by regionally injuring the brain superior colliculus with the use of a legion generator. The animal model of urinary dysfunction is useful in a method of screening a therapeutic agent for urinary dysfunction.